Neurocrine Biosciences' Huntington's disease drug gets FDA approval

By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tu...

Related Keywords

Bengaluru ,Karnataka ,India ,Alan Barona ,Industrie Austdedo ,Phil Nadeau ,Neurocrine Bioscience Ingrezza ,Reuters ,Drug Administration ,Sruthi Narasimha ,Ingrezza Sprinkle ,Teva Pharmaceutical Industrie Austdedo ,Sruthi Narasimha Chari ,Mariam Sunny , ,